Advancing Lung Cancer Care in the U.S.
As a National Cancer Institute-designated Comprehensive Cancer Center, the Duke Cancer Institute helped pioneer minimally invasive surgery techniques. We are also a member of the National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers dedicated to improving patient care and the the National Cancer Trials Network, which coordinates national clinical trials.
Decades of Duke Research Inform Your Treatment
Using a large tissue bank and database of patients treated for lung cancer at Duke since 1995, our medical oncologists study why some lung cancer patients respond to treatments differently than others. This information can help us better treat your specific type of cancer and minimize your symptoms. We have also developed several FDA-approved drugs that help improve outcomes.
If Lung Cancer Spreads to Brain or Spine
We offer new treatments that make it possible for people to live longer with better quality of life when cancer has spread to the brain or spine. Our experts in the medical, surgical, and radiological management of metastatic brain and spine tumors use advanced therapies, which may not be available at other centers, to extend life for our people with metastatic brain and spine cancer.
Access to Clinical Trials
Every day, our researchers conduct approved clinical trials to develop new treatment options and give more insights into curing lung cancer and improving our patients’ quality of life. You may be eligible to participate in our clinical trials, which are designed to increase your treatment options and enhance your care.